You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Mallinckrodt
McKesson
Colorcon
AstraZeneca

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Sandoz, Inc. (D. Nev. 2008)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Bayer Schering Pharma AG v. Sandoz, Inc. (D. Nev. 2008)

Docket   Start Trial Date Filed 2008-08-01
Court District Court, D. Nevada Date Terminated 2013-08-22
Cause 35:271 Patent Infringement Assigned To Kent J. Dawson
Jury Demand Both Referred To Magistrate Judge George Foley,
Parties BAYER HEALTHCARE PHARMACEUTICALS INC.; BAYER SCHERING PHARMA AG; SANDOZ, INC.
Patents 5,569,652; RE37,564; RE37,838
Attorneys Adam K Mortara; Andrew P Gordon; Dan C. Bowen; Delphine W. Knight Brown; Jonathan W Fountain; Joseph A Boyle; Mark T. Jansen; Michael J. McCue; Paul J Skiermont; Peter B. Bensinger , Jr.; Steven J Moore; Sundeep K. Addy; Vincent P Rao , II
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Schering Pharma AG v. Sandoz, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Sandoz, Inc. (D. Nev. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-08-01 1 Contraception", 7, Suppl. 3, pp. 5,569,652 A 10/1996 Beier et al. …Contraception", 12, pp. 155-156, 5,569,652 A 10/1996 Beier et al. 514/173… 25 identical patents-in-suit and identical theories of patent infringement. … PATENTS-IN-SUIT 24 13. United States Reissue Patent No. …their application for this patent on February 15, 2000. The ‘564 reissue patent was issued External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Johnson and Johnson
Express Scripts
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.